Metabolomics in detection of Chemotoxicity

Chemotherapy drugs capable to cause significant, irreversible, life threatening organ damage which is distressing for patients and might affect the optimal delivery of treatment. Various studies have predicted the risk factors for drug induced organ damage because of lack of biomarker to pick-up these changes in early phase causes potential morbidity and mortality. Metabolomics can address relation between gene, drugs environment and thus increase our ability to predict individual variation in drug response phenotypes.

    Related Conference of Metabolomics in detection of Chemotoxicity

    February 22-23, 2023

    International Bio Summit and Expo

    London, UK
    April 17-18, 2023

    13th World Glycobiology Congress

    Rome, Italy
    June 19-20, 2023

    5th International Conference on Biochemistry

    London, UK
    June 19-20, 2023

    5th International Conference on Nucleic Acids

    London, UK
    June 27-28, 2023

    13th Annual Summit on Advanced Bionics

    Vienna, Austria
    September 21-22, 2023

    19th World Congress on Structural Biology

    Paris, France
    September 21-22, 2023

    14th International Conference on Biofuels and Bioenergy

    Toronto, Canada
    October 30-31, 2023

    14th World Congress on Cell & Tissue Science

    Rome, Italy
    November 01-02, 2023

    19th International Conference on Metabolomics

    Rome, Italy

    Metabolomics in detection of Chemotoxicity Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in